According to The Business Research Company’s Anticoagulants , The anticoagulants market size has grown rapidly in recent years. It will grow from $45.18 billion in 2023 to $49.89 billion in 2024 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to aging population, increased prevalence of cardiovascular diseases, rising awareness about the importance of anticoagulant therapy, expansion of indications for anticoagulant use, increased incidence of venous thromboembolism (vte) and atrial fibrillation..
Learn More On The Anticoagulants Market:
https://www.thebusinessresearchcompany.com/report/anticoagulant-global-market-report
The anticoagulants market size is expected to see rapid growth in the next few years. It will grow to $77.71 billion in 2028 at a compound annual growth rate (CAGR) of 11.7%. The growth in the forecast period can be attributed to expansion of indications for novel anticoagulant drugs, rising healthcare expenditure, emergence of novel oral anticoagulants (noacs) as primary treatment options, financial support offered by central authorities to revamp healthcare facilities, expansion of the healthcare infrastructure.
Major trends in the forecast period include advancements in medical technologies and diagnostic methods, integration of artificial intelligence and data analytics in anticoagulant therapy, growing emphasis on patient education and adherence programs, development of reversal agents.The increasing cardiovascular diseases are a key factor driving the growth of the anticoagulants market over the coming years. CVDs (cardiovascular diseases) are a category of heart and blood vessel problems. Cardiovascular diseases (CVDs) are the primary, source of death worldwide with low- and middle-income nations accounting for three-quarters of CVD deaths. Anticoagulation pharmacotherapy known as direct oral anticoagulants is used to minimize thrombosis in a variety of cardiovascular situations. According to the World Health Organization report in 2021, cardiovascular diseases claimed the lives of 17.9 million individuals worldwide, accounting for 32% of all deaths. Heart attacks and strokes were responsible for 85% of these deaths. Therefore, the increasing cardiovascular diseases drive the growth of the anticoagulants market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=5230&type=smp
The anticoagulants market covered in this report is segmented –
1) By Drug Class: Factor Xa Inhibitor, Heparin And LMWH, Vitamin K Antagonist, Other Drug Classes
2) By Route Of Administration: Oral Anticoagulant, Injectable Anticoagulant
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
4) By Application: Venous Thromboembolism, Atrial Fibrillation Or Flutter, Coronary Artery Disease, Other Applications
5) By End User: Hospitals, Homecare, Specialty Centers, Other End-Users
Top Major Players
GlaxoSmithKline plc
Leo Pharma A/S
Alexion Pharmaceuticals Inc.
Amphastar Pharmaceuticals Inc.
Bayer AG, Boehringer Ingelheim International GmbH
The ongoing clinical trials of anticoagulant treatments for COVID-19 are shaping the anticoagulants market. Major companies operating in the anticoagulants sector are concentrating on establishing clinical trials of anticoagulant medications to lower the risk of COVID-19-related blood clotting in adults. For instance, in March 2021, The National Institutes of Health (NIH) in the USA started the final of three Phase III clinical trials of blood thinners (anticoagulants) to prohibit life-threatening blood clots in elderly people with COVID-19. The ACTIV-4 trials will help to resolve concerns about the use of anticoagulants also known as antithrombotics in the treatment of COVID-19.
The anticoagulants market report table of contents includes:
1. Executive Summary
2. Anticoagulants Market Characteristics
3. Anticoagulants Market Trends And Strategies
4. Anticoagulants Market – Macro Economic Scenario
5. Global Anticoagulants Market Size and Growth
…………………..
31. Global Anticoagulants Market Competitive Benchmarking
32. Global Anticoagulants Market Competitive Dashboard
33. Key Mergers And Acquisitions In The Anticoagulants Market
34. Anticoagulants Market Future Outlook and Potential Analysis
35. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
